Dr. Nimesh Desai interviewed about the Mesoblast COVID-19 ARDS trail.
The interview was facilitated by CureTalks.com, in association with the University of Pennsylvania.
UPenn is one of the sites for the ARDS trial and Dr. Nimesh Desai is the Principal Investigator.
One of the interviewers is Jack Aiello, a famous patient advocate for Multiple Myeloma.
PS: Any day now folks. Really. Any day.
ARDS Trial - From UPenn Principal Investigator
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.020(1.87%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $7.968M | 7.258M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 155863 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 50009 | 15 |
View Market Depth
| Last trade - 13.16pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.020 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1254744 | ||
| Last updated 13.31pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |